<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-06T21:04:27Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/11987" metadataPrefix="edm">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/11987</identifier><datestamp>2026-09-04T00:05:21Z</datestamp><setSpec>com_10259_6168</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_4323</setSpec><setSpec>col_10259_6169</setSpec><setSpec>col_10259_4330</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xsi:schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# http://www.europeana.eu/schemas/edm/EDM.xsd">
<edm:ProvidedCHO rdf:about="https://hdl.handle.net/10259/11987">
<dc:creator>Huerta Sainz, Sergio de la</dc:creator>
<dc:creator>Diez Cabanes, Valentin</dc:creator>
<dc:creator>Gutiérrez Vega, Alberto</dc:creator>
<dc:creator>Martel Martín, Sonia</dc:creator>
<dc:creator>Fernández Pampín, Natalia</dc:creator>
<dc:creator>Rumbo Lorenzo, Carlos</dc:creator>
<dc:creator>Marcos Villa, Pedro A.</dc:creator>
<dc:creator>Bol Arreba, Alfredo</dc:creator>
<dc:creator>Marson, Domenico</dc:creator>
<dc:creator>Laurini, Erik</dc:creator>
<dc:creator>Aparicio Martínez, Santiago</dc:creator>
<dc:date>2026-09</dc:date>
<dc:description>Essential-oil nanocapsules are bio-based antimicrobial formulations central to agri-food sustainability, yet their human and environmental hazard as formulated products cannot be assessed by conventional molecular QSAR, which ignores controlled release kinetics, nano-specific bio-interactions, and shell-material contributions. We apply a systems toxicology approach — integrating molecular QSAR (Tier 1), Korsmeyer–Peppas release kinetics (Tier 2), and a nano-specific bioavailability correction layer (Tier 3) — to produce the first quantitative integrated hazard prediction for two clove-oil advanced-material (AdMa) nanocapsule formulations: AdMa EO@PEC-GEL (pectin–gelatin shell, CaCl₂ crosslinker) and AdMa EO@Chi (chitosan shell, formaldehyde crosslinker).Eugenol (∼90 wt% core) is the principal toxicophore. Release parameters were scaled from published eugenol–chitosan kinetic data to the 1 μm target particle size; nano-correction factors were calibrated from published surface-charge and uptake relationships. The integrated model predicts AdMa EO@PEC-GEL to be 9.1× safer than free eugenol (IC₅₀ ∼3.5 mM vs. 0.38 mM), driven by anionic surface charge and 80% encapsulation efficiency. AdMa EO@Chi retains toxicity close to the free molecule (IC₅₀ ∼0.91 mM; 2.4×) because cationic surface charge offsets the encapsulation benefit. The formaldehyde crosslinker introduces independent sensitisation, genotoxicity, and IARC Group 1 carcinogenicity flags — quantified via the concentration-addition mixture model — entirely absent from PEC-GEL.Sensitivity analysis identifies zeta potential as the dominant model uncertainty driver. Tier 2 is retrospectively validated against published release kinetics (R2 = 0.997). The Korsmeyer–Peppas tier applies directly to environmental fate scenarios — pH-dependent shell dissolution in soil and aquatic compartments — providing a unified architecture for human–environment integrated hazard assessment aligned with planetary health priorities. An interactive, browser-based digital twin is provided as Supplementary Information: it recomputes all integrated predictions in real time as the user adjusts the model inputs (zeta potential, particle size, encapsulation efficiency, eugenol fraction, release time and pH/enzyme condition), enabling transparent scenario analysis and progressive refinement as experimental data become available, in line with the iterative Safe-and-Sustainable-by-Design (SSbD) workflow.</dc:description>
<dc:format>application/pdf</dc:format>
<dc:identifier>https://hdl.handle.net/10259/11987</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>Elsevier</dc:publisher>
<dc:title>A three-tier in silico toxicology framework for formulated essential-oil nanocapsules: integrating molecular hazard, release kinetics and nano-bioavailability for safe-and-sustainable-by-design assessment</dc:title>
<dc:type>info:eu-repo/semantics/article</dc:type>
<edm:type>TEXT</edm:type>
</edm:ProvidedCHO>
<ore:Aggregation rdf:about="https://hdl.handle.net/10259/11987#aggregation">
<edm:aggregatedCHO rdf:resource="https://hdl.handle.net/10259/11987"/>
<edm:dataProvider>RIUBU. Repositorio Institucional de la Universidad de Burgos</edm:dataProvider>
<edm:isShownAt rdf:resource="https://hdl.handle.net/10259/11987"/>
<edm:isShownBy rdf:resource="https://riubu.ubu.es/bitstream/10259/11987/1/Gutierrez-CT_2026.pdf"/>
<edm:object rdf:resource="https://riubu.ubu.es/bitstream/10259/11987/4/Gutierrez-Vega-CT_2026.pdf.jpg"/>
<edm:provider>Hispana</edm:provider>
<edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc-nd/4.0/"/>
</ore:Aggregation>
<edm:WebResource rdf:about="https://riubu.ubu.es/bitstream/10259/11987/1/Gutierrez-CT_2026.pdf">
<edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc-nd/4.0/"/>
</edm:WebResource>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>